BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27400194)

  • 1. Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
    Bishop JA; French CA; Ali SZ
    Cancer Cytopathol; 2016 Dec; 124(12):901-908. PubMed ID: 27400194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.
    Agaimy A; Haller F; Renner A; Niedermeyer J; Hartmann A; French CA
    Am J Surg Pathol; 2022 Feb; 46(2):281-288. PubMed ID: 34232599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion.
    Shah A; Box A; Brenn T; Flaman A
    J Cutan Pathol; 2024 Jun; 51(6):424-429. PubMed ID: 38481096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary pulmonary NUT midline carcinoma: An elusive and a rare diagnostic entity.
    Pasricha S; Jajodia A; Sharma A; Bansal D; Batra U; Gupta G; Durga G; Kamboj M; Nathany S; Mehta A
    J Cancer Res Ther; 2023; 19(3):816-818. PubMed ID: 37470617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring cytologic features and potential diagnostic challenges of metastatic NUT carcinoma to the parotid gland: A case report and a comprehensive literature review.
    Li CY; Salihoglu S; Civantos FJ; Velez Torres JM
    Diagn Cytopathol; 2024 Apr; ():. PubMed ID: 38655736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report and Literature Review: Primary Pulmonary NUT-Midline Carcinoma.
    Zhang Y; Han K; Dong X; Hou Q; Li T; Li L; Zhou G; Liu X; Zhao G; Li W
    Front Oncol; 2021; 11():700781. PubMed ID: 34527578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.
    Stathis A; Zucca E; Bekradda M; Gomez-Roca C; Delord JP; de La Motte Rouge T; Uro-Coste E; de Braud F; Pelosi G; French CA
    Cancer Discov; 2016 May; 6(5):492-500. PubMed ID: 26976114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUT carcinoma - An aggressive thoracic tumor.
    Ribeiro JA; Sousa J; Jesus F; Almeida É; Costa JF; Reis M; Gomes RM
    Am J Med Sci; 2023 Jul; 366(1):64-70. PubMed ID: 37100347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NUTM1-fusion positive malignant neoplasms of the genitourinary tract: A report of six cases highlighting involvement of unusual anatomic locations and histologic heterogeneity.
    Xu B; Chen JF; Sarungbam J; Tickoo S; Dickson BC; Reuter VE; Antonescu CR
    Genes Chromosomes Cancer; 2022 Sep; 61(9):542-550. PubMed ID: 35430756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLE1 Expression in NUT Carcinoma: A Case Report Highlighting a Potential Diagnostic Pitfall for the Pathologist.
    Aziz SJ; Dickson BC; Lang P; Zeman CE
    Int J Surg Pathol; 2024 Jan; ():10668969231217750. PubMed ID: 38233028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients.
    Chau NG; Ma C; Danga K; Al-Sayegh H; Nardi V; Barrette R; Lathan CS; DuBois SG; Haddad RI; Shapiro GI; Sallan SE; Dhar A; Nelson JJ; French CA
    JNCI Cancer Spectr; 2020 Apr; 4(2):pkz094. PubMed ID: 32328562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary pulmonary NUT carcinoma: a clinicopathological analysis of seven cases].
    Zhuang XP; Huang HJ; Chen X; Zheng SL; Li BC; Sun H
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1244-1248. PubMed ID: 38058041
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.
    Chen M; Li S; Jiang L
    Front Oncol; 2023; 13():1296862. PubMed ID: 38239638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expanding universe of NUTM1 fusions in pediatric cancer.
    Charlab R; Racz R
    Clin Transl Sci; 2023 Aug; 16(8):1331-1339. PubMed ID: 37082775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of Molecular Mechanism, Clinicopathological Factors, and Treatment in NUT Carcinoma.
    Huang QW; He LJ; Zheng S; Liu T; Peng BN
    Biomed Res Int; 2019; 2019():1018439. PubMed ID: 31815119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Protein in Testis (NUT) Carcinoma: A Comprehensive Immunohistochemical Analysis of 57 Cases With Consideration of Interpretation and Pitfall Recognition.
    Farooq A; Kerper AL; Boland JM; Lo YC
    Arch Pathol Lab Med; 2023 Dec; ():. PubMed ID: 38059551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histological spectrum and immunoprofile of head and neck NUT carcinoma: A multicentre series of 30 cases.
    Viswanathan K; Hahn E; Dogan S; Weinreb I; Dickson BC; MacMillan C; Katabi N; Magliocca K; Ghossein R; Xu B
    Histopathology; 2024 May; ():. PubMed ID: 38708903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Top 10 Basaloid Neoplasms of the Sinonasal Tract.
    Baněčková M; Cox D
    Head Neck Pathol; 2023 Mar; 17(1):16-32. PubMed ID: 36928732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rare Case of P63-Negative Sinonasal Nut Midline Carcinoma in the Elderly.
    Qayum A; Khan MWZ; Arshad AR; Hasnain S; Tariq MD; Khan S; Ullah S
    Eur J Case Rep Intern Med; 2024; 11(2):004265. PubMed ID: 38352806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
    Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
    Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.